BioCardia, Inc. (BCDA) vs IN8bio, Inc. (INAB)
A side-by-side comparison of BioCardia, Inc. and IN8bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BCDA
BioCardia, Inc.
$1.09HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
INAB
IN8bio, Inc.
$1.42HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BCDA vs INAB
growth of $100 · dividends reinvested · last 5yBCDA -99.3% (-62.9%/yr)INAB -99.5% (-65.7%/yr)BCDA compounded faster over this window
BCDA INAB
BCDA vs INAB: by the numbers
- •BCDA is the larger company ($16M vs $14M market cap).
Metrics side by side
Valuation
| Metric | BCDA | INAB |
|---|---|---|
| P/B ratio | 6.01 | 0.74 |
Profitability
| Metric | BCDA | INAB |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -271.81% | -101.66% |
| ROIC | -273.70% | -91.74% |
Growth (annualized)
| Metric | BCDA | INAB |
|---|---|---|
| Total return CAGR (5Y) | -61.39% | -62.88% |
Frequently asked
- How have BCDA and INAB total returns compared?
- Over the past 5 years, BCDA delivered -61.39% and INAB delivered -62.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.